首页> 外文期刊>BJU international >The clinical implications of telomerase activity in upper tract urothelial cancer and washings.
【24h】

The clinical implications of telomerase activity in upper tract urothelial cancer and washings.

机译:端粒酶活性在上尿路尿路上皮癌和洗液中的临床意义。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To measure telomerase activity in upper tract urothelial carcinomas (as renal pelvic tumours comprise nearly half of all kidney tumours in Taiwan, a much higher percentage than in other countries) and to determine whether telomerase activity could be used as an additional diagnostic marker in exfoliated cancer cells present in upper tract urothelial washing fluids, thus providing earlier diagnosis and treatment. Materials and methods Telomerase activity was assessed using the telomeric repeat amplification protocol assay in tissue samples from 31 upper tract urothelial carcinomas (from 29 patients). The feasibility of identifying cancer using telomerase activity in exfoliated cancer cells in 17 upper tract urothelial washing samples was also investigated. RESULTS: Telomerase activity was found in 30 (97%) of the 31 upper tract urothelial cancer tissue samples; telomerase activity was detectable in 95% of superficial cancers and in all 11 invasive tumours. The sensitivity of measuring telomerase activity was 100% for grade 1, 93% for grade 2 and 100% for grade 3 tumours. In contrast, telomerase activity was detected in only two (8%) of 26 normal adjacent tissue samples. When the telomerase activity of urothelial washing fluid was compared with that in the corresponding tumours, there was compatible telomerase activity in 15 of the 17 samples. Telomerase activity was more sensitive than voided urine cytology (15%) and washing fluid cytology (53%). In addition, the telomerase activity was high in metastatic lesions. CONCLUSION: Telomerase activity is present in most upper tract urothelial cancer tissues and may be present at an early stage of carcinogenesis. Telomerase activity can be detected in exfoliated cells in urothelial washing fluids in a high proportion of patients with upper tract urothelial cancer. These results suggest that measuring telomerase activity in the exfoliated cancer cells obtained from urothelial washing could be a potentially useful addition to the conventional diagnostic tools used to identify patients with upper tract urothelial carcinoma.
机译:目的:测量上尿路尿路上皮癌的端粒酶活性(由于肾盂肿瘤占台湾所有肾肿瘤的近一半,比其他国家的比例高得多),并确定端粒酶活性是否可以用作其他诊断指标存在于上尿路尿路上皮冲洗液中的脱落的癌细胞,从而提早诊断和治疗。材料和方法使用端粒重复扩增方案分析评估了31例上尿路上皮癌(29例患者)的组织样本中的端粒酶活性。还研究了在17个上尿路尿路上皮清洗样本中使用脱落的端粒酶活性鉴定癌症的可行性。结果:在31个上尿路尿路上皮癌组织样本中有30个(97%)发现端粒酶活性。在95%的浅表癌症和所有11种浸润性肿瘤中均可检测到端粒酶活性。测量端粒酶活性的敏感性,对于1级肿瘤为100%,对于2级肿瘤为93%,对于3级肿瘤为100%。相反,在26个正常相邻组织样本中仅两个(8%)检测到端粒酶活性。当将尿路上皮冲洗液的端粒酶活性与相应肿瘤中的端粒酶活性进行比较时,在17个样品中的15个中有相容的端粒酶活性。端粒酶活性比尿液细胞学检查(15%)和冲洗液细胞学检查(53%)更敏感。另外,在转移灶中端粒酶活性很高。结论:端粒酶活性存在于大多数上尿路尿路上皮癌组织中,并且可能存在于癌变的早期。上皮尿路上皮癌患者中有很大比例的尿路上皮冲洗液脱落细胞中可以检测到端粒酶活性。这些结果表明,测量从尿路上皮清洗获得的脱落的癌细胞中的端粒酶活性可能是用于鉴定上尿路尿路上皮癌患者的常规诊断工具的潜在有用补充。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号